Randomized study to compare olmesartan + azelnidipine versus valsartan + amlodipine to maximize blood pressure control and organ protection.

Trial Profile

Randomized study to compare olmesartan + azelnidipine versus valsartan + amlodipine to maximize blood pressure control and organ protection.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2014

At a glance

  • Drugs Amlodipine; Azelnidipine; Olmesartan medoxomil; Valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 26 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top